Executive Briefing on ORAL ONCOLYTICS

The 16 page whitepaper includes:

  • Understand the realities and trade-offs for oral therapeutics

  • Strategic perspectives and pharma case examples

  • Learn about the next frontier of new agents

Please subscribe to view the analysis report